1632 Federal Register / Vol. 73, No. 6 / Wednesday, January 9, 2008 / Notices 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6101 

Executive Boulevard, Rockville, MD 20852, 

(Virtual Meeting). 

Contact Person: Mark Swieter, PhD, Chief, 

Training and Special Projects Review Branch, 

Office of Extramural Affairs, National 

Institute on Drug Abuse, NIH, DHHS, 6101 

Executive Boulevard, Suite 200, Bethesda, 

MD 20892–8401, (301) 435–1389, 

ms80x@nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, NIDA F 

New Investigator R01 Member Conflicts. 

Date: February 15, 2008. 

Time: 12 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6101 

Executive Boulevard, Rockville, MD 20852, 

(Telephone Conference Call). 

Contact Person: Gerald L. McLaughlin, 

PhD, Scientific Review Administrator, Office 

of Extramural Affairs, National Institute on 

Drug Abuse, NIH, DHHS, Room 220, MSC 

8401, 6101 Executive Blvd., Bethesda, MD 

20892–8401, 301–402–6626, 

gm145a@nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, NIDA–

F New Investigator R01s Sep. 

Date: February 15, 2008. 

Time: 12 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6101 

Executive Boulevard, Rockville, MD 20852, 

(Telephone Conference Call). 

Contact Person: Meenaxi Hiremath, PhD, 

Health Scientist Administrator, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, National Institutes of Health, 

DHHS, 6101 Executive Blvd., Suite 220, MSC 

8401, Bethesda, MD 20892, 301–402–7964, 

mh392g@nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Initial Review Group, Health 

Services Research Subcommittee. 

Date: March 4–5, 2008. 

Time: 8:30 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Jurys Washington Hotel, 1500 New 

Hampshire Ave. NW., Washington, DC 

20036. 

Contact Person: Meenaxi Hiremath, PhD, 

Health Scientist Administrator, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, National Institutes of Health, 

DHHS, 6101 Executive Blvd., Suite 220, MSC 

8401, Bethesda, MD 20892, 301–402–7964, 

mh392g@nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Initial Review Group, Treatment 

Research Subcommittee. 

Date: March 4–5, 2008. 

Time: 9 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Jurys Washington Hotel, 1500 New 

Hampshire Avenue, NW., Washington, DC 

20036. 

Contact Person: Kesinee Nimit, MD., 

Health Scientist Administrator, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, NIH, DHHS, Room 220, MSC 

8401, 6101 Executive Boulevard, Bethesda, 

MD 20892–8401, (301) 435–1432. 

Name of Committee: National Institute on 

Drug Abuse Initial Review Group, Training 

and Career Development Subcommittee. 

Date: March 11–13, 2008. 

Time: 9 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Melrose Hotel, 2430 Pennsylvania 

Ave., NW., Washington, DC 20037. 

Contact Person: Eliane Lazar-Wesley, PhD, 

Health Scientist Administrator, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, NIH, DHHS, 6101 Executive 

Boulevard, Room 220, MSC 8401, Bethesda, 

MD 20892–8401, 301–451–4530, 

el6r@nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Initial Review Group, 

Medication Development Research 

Subcommittee. 

Date: March 13, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Omni Shoreham Hotel, 2500 Calvert 

Street, NW., Washington, DC 20008. 

Contact Person: Gerald L. McLaughlin, 

PhD, Health Scientist Administrator, Office 

of Extramural Affairs, National Institute on 

Drug Abuse, NIH, DHHS, Room 220, MSC 

8401, 6101 Executive Boulevard, Bethesda, 

MD 20892–8401, 301–402–6626, 

gm145a@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.279, Drug Abuse and 

Addiction Research Programs, National 

Institutes of Health, HHS) 

Dated: January 3, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 08–43 Filed 1–8–08; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, 

Synthesis and Distribution of Drugs of Abuse 

and Related Compounds. 

Date: January 23, 2008. 

Time: 9 a.m. to 4 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Courtyard by Marriott Rockville, 

2500 Research Boulevard, Rockville, MD 

20850. 

Contact Person: Lyle Furr, Contract Review 

Specialist, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, Room 220, MSC 8401, 6101 Executive 

Boulevard, Bethesda, MD 20892–8401, (301) 

435–1439, lf33c.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, Drug 

Abuse Screening, Assessment, PatientTreatment Matching Technologies for Use in 

Primary Care. 

Date: January 24, 2008. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6101 

Executive Boulevard, Rockville, MD 20852, 

(Telephone Conference Call). 

Contact Person: Kristen V. Huntley, PhD., 

Scientific Review Administrator, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, NIH, DHHS, Room 220, MSC 

8401, 6101 Executive Boulevard, Bethesda, 

MD 20892–8401, 301–435–1433, 

huntleyk@mail.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, 

Development of Nanoscience-based Probes, 

Delivery Systems, and Therapies for 

Substance Use Disorders. 

Date: January 30, 2008. 

Time: 9 a.m. to 5 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Courtyard by Marriott Rockville, 

2500 Research Boulevard, Rockville, MD 

20850. 

Contact Person: Lyle Furr, Contract Review 

Specialist, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, Room 220, MSC 8401, 6101 Executive 

Boulevard, Bethesda, MD 20892–8401, (301) 

435–1439, lf33c.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.279, Drug Abuse and 

Addiction Research Programs, National 

Institutes of Health, HHS) 

Dated: January 3, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 08–44 Filed 1–8–08; 8:45 am] 

BILLING CODE 4140–01–M 


pwalker on PROD1PC71 with NOTICES